{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T18:26:30Z","timestamp":1795026390715,"version":"4.10.2"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>Counseling about potential side effects and health benefits of contraceptive methods could facilitate continued method use and method satisfaction, yet no evidence-based compilation of side effects and benefits exists to aid such counseling. Among contraceptive methods in the United States, depot medroxyprogesterone acetate (DMPA) injectables have the highest discontinuation rates, and most discontinuation is attributable to side effects. This review examines the side effects and health benefits of DMPA to inform counseling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DATA SOURCES:<\/jats:title>\n                    <jats:p>We searched PubMed, POPLINE, EMBASE, Web of Science, Campbell Collaboration Library of Systematic Reviews, the Cochrane Database of Systematic Reviews, the Cochrane Center Register of Controlled Trials, and ClinicalTrials.gov.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS OF STUDY SELECTION:<\/jats:title>\n                    <jats:p>We included English-language studies published from 1985 to 2016 that enrolled healthy, nonbreastfeeding females aged 13\u201349 years at risk of unintended pregnancy, compared intramuscular or subcutaneous progestin-only injectables to a contemporaneous comparison group, and addressed at least one key question: 1) What side effects are associated with progestin-only injectable contraceptive use? 2) What health benefits are associated with progestin-only injectable contraceptive use? Study quality was assessed using criteria from the U.S. Preventive Services Task Force.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>TABULATION, INTEGRATION, AND RESULTS:<\/jats:title>\n                    <jats:p>Twenty-four studies met inclusion criteria. None were randomized controlled trials. There were 13 prospective cohort, five retrospective cohort, four case\u2013control, and two cross-sectional studies. Studies of moderate or high risk of bias suggest an association between DMPA use and weight gain, increased body fat mass, irregular bleeding, and amenorrhea. Inconsistent evidence exists for an association between DMPA use and mood or libido changes. Limited evidence exists for an association between DMPA use and decreased risk of cancers and tubal infertility.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Higher-quality research is needed to clarify DMPA's side effects and benefits. In absence of such evidence, patient-centered counseling should incorporate the available evidence while acknowledging its limitations and recognizing the value of women's lived experiences.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000003089","type":"journal-article","created":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T10:36:52Z","timestamp":1548326212000},"page":"332-341","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":31,"title":["Side Effects and Health Benefits of Depot Medroxyprogesterone Acetate"],"prefix":"10.1097","volume":"133","author":[{"given":"Shokoufeh","family":"Dianat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine A.","family":"Ahrens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ushma D.","family":"Upadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera M.","family":"Zlidar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria F.","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reva L.","family":"Stidd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Moskosky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Dehlendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-20261118","doi-asserted-by":"crossref","first-page":"46.e1","DOI":"10.1016\/j.ajog.2015.01.051","article-title":"The role of contraceptive attributes in women's contraceptive decision making","volume":"213","author":"Madden","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"R3-20261118","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1363\/4419412","article-title":"Contraceptive features preferred by women at high risk of unintended pregnancy","volume":"44","author":"Lessard","year":"2012","journal-title":"Perspect Sex Reprod Health"},{"key":"R4-20261118","first-page":"608","article-title":"Advance information improves user satisfaction with the levonorgestrel intrauterine system","volume":"99","author":"Backman","year":"2002","journal-title":"Obstet Gynecol"},{"key":"R5-20261118","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0010-7824(96)00085-6","article-title":"Effect of pretreatment counseling on discontinuation rates in Chinese women given depo-medroxyprogesterone acetate for contraception","volume":"53","author":"Lei","year":"1996","journal-title":"Contraception"},{"key":"R6-20261118","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0010-7824(01)00181-0","article-title":"Effect of counseling to improve compliance in Mexican women receiving depot-medroxyprogesterone acetate","volume":"63","author":"Canto De Cetina","year":"2001","journal-title":"Contraception"},{"key":"R8-20261118","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1023\/A:1026643621387","article-title":"Perceptions of hormonal contraceptive safety and side effects among low-income Latina and non-Latina women","volume":"4","author":"Guendelman","year":"2000","journal-title":"Matern Child Health J"},{"key":"R9-20261118","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.contraception.2012.10.012","article-title":"Women's preferences for contraceptive counseling and decision making","volume":"88","author":"Dehlendorf","year":"2013","journal-title":"Contraception"},{"key":"R10-20261118","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1353\/hpu.2011.0144","article-title":"Perceptions of coercion, discrimination and other negative experiences in postpartum contraceptive counseling for low-income minority women","volume":"22","author":"Yee","year":"2011","journal-title":"J Health Care Poor Underserved"},{"key":"R11-20261118","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1363\/psrh.12017","article-title":"Contraceptive failure in the United States: estimates from the 2006\u20132010 national Survey of family growth","volume":"49","author":"Sundaram","year":"2017","journal-title":"Perspect Sex Reprod Health"},{"key":"R13-20261118","first-page":"1","article-title":"U.S. medical eligibility criteria for contraceptive use, 2016","volume":"65","author":"Curtis","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"R15-20261118","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jadohealth.2009.04.009","article-title":"A longitudinal comparison of body composition changes in adolescent girls receiving hormonal contraception","volume":"45","author":"Bonny","year":"2009","journal-title":"J Adolesc Health"},{"issue":"2 suppl 1","key":"R16-20261118","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.amepre.2015.03.033","article-title":"Systematic review evidence methodology: providing quality family planning Services","volume":"49","author":"Tregear","year":"2015","journal-title":"Am J Prev Med"},{"key":"R19-20261118","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.contraception.2015.12.010","article-title":"Racial and ethnic differences in women's preferences for features of contraceptive methods","volume":"93","author":"Jackson","year":"2016","journal-title":"Contraception"},{"key":"R20-20261118","doi-asserted-by":"crossref","DOI":"10.1071\/SH15189","article-title":"What qualities of long-acting reversible contraception do women perceive as desirable or undesirable? A systematic review","author":"Coombe","year":"2016","journal-title":"Sex Health"},{"key":"R21-20261118","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3109\/13625187.2014.936934","article-title":"Body composition and weight gain in new users of the three-monthly injectable contraceptive, depot-medroxyprogesterone acetate, after 12 months of follow-up","volume":"19","author":"dos Santos Pde","year":"2014","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"R22-20261118","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1007\/s00404-016-4192-9","article-title":"Binge eating and biochemical markers of appetite in new users of the contraceptive depot medroxyprogesterone acetate","volume":"294","author":"Silva dos Santos","year":"2016","journal-title":"Arch Gynecol Obstet"},{"key":"R23-20261118","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1590\/2359-3997000000202","article-title":"Body composition, resting energy expenditure and inflammatory markers: impact in users of depot medroxyprogesterone acetate after 12 months follow-up","volume":"61","author":"Batista","year":"2017","journal-title":"Arch Endocrinol Metab"},{"key":"R24-20261118","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/sj.ijo.0803023","article-title":"Weight, fat mass and central distribution of fat increase when women use depot-medroxyprogesterone acetate for contraception","volume":"29","author":"Clark","year":"2005","journal-title":"Int J Obes"},{"key":"R25-20261118","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/13625187.2014.951433","article-title":"Weight variation in users of depot-medroxyprogesterone acetate, the levonorgestrel-releasing intrauterine system and a copper intrauterine device for up to ten years of use","volume":"20","author":"Modesto","year":"2015","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"R26-20261118","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0010-7824(01)00255-4","article-title":"Comparison of weight increase in users of depot medroxyprogesterone acetate and copper IUD up to 5 years","volume":"64","author":"Bahamondes","year":"2001","journal-title":"Contraception"},{"key":"R27-20261118","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0010-7824(99)00037-2","article-title":"Effects of DMPA on weight and blood pressure in long term acceptors","volume":"59","author":"Taneepanichskul","year":"1999","journal-title":"Contraception"},{"key":"R28-20261118","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0010-7824(98)00085-7","article-title":"Comparative study of weight change between long-term DMPA and IUD acceptors","volume":"58","author":"Taneepanichskul","year":"1998","journal-title":"Contraception"},{"key":"R29-20261118","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.contraception.2014.03.011","article-title":"Body weight and body composition of depot medroxyprogesterone acetate users","volume":"90","author":"Dal'Ava","year":"2014","journal-title":"Contraception"},{"key":"R30-20261118","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.contraception.2009.07.008","article-title":"Variations in body mass index of users of depot-medroxyprogesterone acetate as a contraceptive","volume":"81","author":"Pantoja","year":"2010","journal-title":"Contraception"},{"key":"R31-20261118","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/j.0001-6349.2004.00296.x","article-title":"Urinary tract infection in the users of depot-medroxyprogesterone acetate","volume":"83","author":"Ziaei","year":"2004","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R32-20261118","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0015-0282(16)56579-0","article-title":"Identification of main risk factors for tubal infertility","volume":"61","author":"Bahamondes","year":"1994","journal-title":"Fertil Steril"},{"key":"R33-20261118","first-page":"186","article-title":"Depot-medroxyprogesterone acetate (DMPA) and risk of epithelial ovarian cancer","volume":"49","author":"Cuevas","year":"1991","journal-title":"Int J Cancer"},{"key":"R34-20261118","first-page":"186","article-title":"Depot-medroxyprogesterone acetate (dmpa) and risk of edometrial cancer","volume":"49","author":"Silpisornkosol","year":"1991","journal-title":"Int J Cancer"},{"key":"R35-20261118","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1471-0528.2012.03298.x","article-title":"Depot medroxyprogesterone acetate and epithelial ovarian cancer: a multicentre case-control study: DMPA and epithelial ovarian cancer","volume":"119","author":"Wilailak","year":"2012","journal-title":"BJOG"},{"key":"R36-20261118","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0010-7824(00)00144-X","article-title":"Depo-provera associated with weight gain in Navajo women","volume":"62","author":"Espey","year":"2000","journal-title":"Contraception"},{"key":"R37-20261118","doi-asserted-by":"crossref","first-page":"329.e1","DOI":"10.1016\/j.ajog.2008.12.052","article-title":"Changes in weight, total fat, percent body fat, and central-to-peripheral fat ratio associated with injectable and oral contraceptive use","volume":"200","author":"Berenson","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"R38-20261118","doi-asserted-by":"crossref","first-page":"351.e1","DOI":"10.1016\/j.ajog.2008.04.048","article-title":"Physiologic and psychologic symptoms associated with use of injectable contraception and 20 \u03bcg oral contraceptive pills","volume":"199","author":"Berenson","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"R39-20261118","doi-asserted-by":"crossref","first-page":"48.e1","DOI":"10.1016\/j.ajog.2012.10.876","article-title":"Validity of perceived weight gain in women using long-acting reversible contraception and depot medroxyprogesterone acetate","volume":"208","author":"Nault","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"R40-20261118","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.contraception.2013.03.004","article-title":"Weight change at 12 months in users of three progestin-only contraceptive methods","volume":"88","author":"Vickery","year":"2013","journal-title":"Contraception"},{"key":"R41-20261118","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0010-7824(00)00122-0","article-title":"Depressive symptoms in users and non-users of depot medroxyprogesterone acetate","volume":"61","author":"Civic","year":"2000","journal-title":"Contraception"},{"key":"R42-20261118","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1300\/J013v47n01_06","article-title":"Well-being, sleep, exercise patterns, and the menstrual cycle: a comparison of natural hormones, oral contraceptives and depo-provera","volume":"47","author":"Brown","year":"2008","journal-title":"Women Health"},{"key":"R43-20261118","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s10508-007-9302-0","article-title":"The influence of hormonal contraception on mood and sexual interest among adolescents","volume":"37","author":"Ott","year":"2008","journal-title":"Arch Sex Behav"},{"key":"R44-20261118","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/AOG.0000000000001286","article-title":"Sexual desire and hormonal contraception","volume":"127","author":"Boozalis","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R45-20261118","doi-asserted-by":"crossref","first-page":"545.e1","DOI":"10.1016\/j.ajog.2010.07.024","article-title":"Oral contraceptives vs injectable progestin in their effect on sexual behavior","volume":"203","author":"Schaffir","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"R46-20261118","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.contraception.2018.09.004","article-title":"Women's preferences for permanent contraception method and willingness to be randomized for a hypothetical trial","volume":"99","author":"Piazza","year":"2019","journal-title":"Contraception"},{"key":"R47-20261118","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.contraception.2015.08.009","article-title":"Acceptability of randomization to levonorgestrel versus copper intrauterine device among women requesting IUD insertion for contraception","volume":"92","author":"Achilles","year":"2015","journal-title":"Contraception"},{"key":"R48-20261118","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.contraception.2014.11.006","article-title":"Rationale and enrollment results for a partially randomized patient preference trial to compare continuation rates of short-acting and long-acting reversible contraception","volume":"91","author":"Hubacher","year":"2015","journal-title":"Contraception"},{"key":"R50-20261118","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1080\/00224499.2017.1419334","article-title":"Contraceptive method choice among young adults: influence of individual and relationship factors","volume":"55","author":"Harvey","year":"2018","journal-title":"J Sex Res"},{"key":"R51-20261118","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1080\/03630240802708523","article-title":"Women's perceptions of influences on their mood","volume":"49","author":"Romans","year":"2009","journal-title":"Women Health"},{"key":"R52-20261118","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1001\/jamapsychiatry.2016.2387","article-title":"Association of hormonal contraception with depression","volume":"73","author":"Skovlund","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"R53-20261118","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1176\/appi.ajp.2017.17060616","article-title":"Association of hormonal contraception with suicide attempts and suicides","volume":"175","author":"Skovlund","year":"2017","journal-title":"Am J Psychiatry"},{"key":"R54-20261118","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.contraception.2018.01.010","article-title":"The relationship between progestin hormonal contraception and depression: a systematic review","volume":"97","author":"Worly","year":"2018","journal-title":"Contraception"},{"key":"R55-20261118","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/00224499.2015.1134425","article-title":"The sexual acceptability of contraception: reviewing the literature and building a new concept","volume":"53","author":"Higgins","year":"2016","journal-title":"J Sex Res"},{"key":"R56-20261118","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1056\/NEJMoa1700732","article-title":"Contemporary hormonal contraception and the risk of breast cancer","volume":"377","author":"M\u00f8rch","year":"2017","journal-title":"N Engl J Med"},{"key":"R57-20261118","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.contraception.2011.04.002","article-title":"Fertility after discontinuation of contraception: a comprehensive review of the literature","volume":"84","author":"Mansour","year":"2011","journal-title":"Contraception"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006250-201902000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T18:02:13Z","timestamp":1795024933000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006250-201902000-00014"}},"subtitle":["A Systematic Review"],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000003089","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"2018-09-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}